In an increasingly competitive research climate, biotech and pharma organizations are constantly searching for effective strategies for reducing risk while maintaining data quality
Toronto, Canada (PRWEB) May 30, 2013
In an increasingly competitive research climate, biotech and pharma organizations are constantly searching for effective strategies for reducing risk while maintaining data quality. Carrying out Central Statistical Monitoring (CSM) offers significant benefit, including: improving data quality and integrity, reducing regulatory submission risk, as well as driving down costs related to on-site monitoring and Source Data Verification (SDV). All the while, CSM adheres to regulatory guidelines on the subject of Risk-Based Monitoring.
This session will give an in-depth examination of Central Statistical Monitoring (CSM). Expert speakers from Gilead Sciences and CluePoints will review the following topics:
- Statistical principles underlying Central Statistical Monitoring
- Similarities and differences between on-site monitoring, key risk indicators and CSM
- Operational challenges in implementing CSM
- Case studies identifying the impact and utility of this unique approach
To learn more about the event visit http://xtalks.com/RBM-central-statistical-monitoring.ashx.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx.
Karen Lim (416) 977-6555 ext 227